Nobilis Health Corp. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2018; Provides Earnings Guidance for the Full Year 2018
Nobilis Health Corp. reported unaudited consolidated earnings results for the first quarter ended March 31, 2018. For the quarter, the company reported total revenues of $64,457,000 against $68,302,000 a year ago. The decrease in total revenue was primarily due to the loss of two key physician groups as well as the discontinuation of the company's Lab Testing ancillary service-line. Loss from operations was $2,750,000 against $3,135,000 a year ago. Loss before income taxes and non-controlling interests was $3,845,000 against $3,757,000 a year ago. Net loss was $3,141,000 or $0.05 per basic and fully diluted share against $2,206,000 or $0.03 per basic and fully diluted share a year ago. Net loss attributable to the company was $3,852,000 against $2,398,000 a year ago. Net cash provided by operating activities was $2,665,000 against $16,532,000 a year ago. Purchase of property and equipment was $641,000 against $3,506,000 a year ago. EBITDA was $3,054,000 against LBITDA of $273,000 a year ago. Adjusted EBITDA was $5,086,000 against $2,013,000 a year ago.
For the full year 2018, the company expects revenue in the range of $345.0 million to $355.0 million and adjusted EBITDA in the range of $57.0 million to $62.0 million.